-
1
Effect of interleukin-1 antagonist on growth of children with colchicine resistant or intolerant FMF
Published 2023-01-01Subjects: Get full text
Article -
2
Interleukin-1 Blockers in Recurrent and Acute Pericarditis: State of the Art and Future Directions
Published 2024-01-01Subjects: Get full text
Article -
3
Is it possible to extend the dose interval of canakinumab treatment in children with familial Mediterranean fever? PeRA group experience
Published 2023-11-01Subjects: Get full text
Article -
4
The Efficacy, Safety and Tolerability of Canakinumab in the Treatment of Familial Mediterranean Fever: A Systematic Review of the Literature
Published 2020-03-01Subjects: Get full text
Article -
5
MACROPHAGE ACTIVATION SYNDROME AS A COMPLICATION OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS – CASE REPORT
Published 2014-05-01Subjects: “…macrophage activation syndrome, systemic juvenile idiopathic arthritis, anti-IL1 therapy…”
Get full text
Article -
6
Long-term renal outcome of Cryopyrin-associated periodic syndrome (CAPS) under anti-Interleukin-1 therapy
Published 2024-07-01Subjects: Get full text
Article -
7
Single Center-Based Real-World Experience on Anti-IL 1 Biological Response Modifiers: A Case Series and Literature Review
Published 2024-09-01Subjects: Get full text
Article -
8
The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives
Published 2018-06-01Subjects: “…anti-IL-1 therapy…”
Get full text
Article -
9
Editorial: Inborn errors of immunity and mucosal immunity
Published 2023-05-01Subjects: Get full text
Article -
10
-
11
NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies
Published 2022-10-01Subjects: Get full text
Article -
12
-
13
Lung Involvement in Systemic Juvenile Idiopathic Arthritis: A Narrative Review
Published 2022-12-01Subjects: Get full text
Article -
14
Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA
Published 2018-11-01Subjects: Get full text
Article